BeStock  
Markets › Compare › NBIX vs UTHR

NBIX vs UTHR

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NBIX · Neurocrine Biosciences$150.57 ▼ 3.84%
UTHR · United Therapeutics$554.73 ▼ 0.78%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8497109122134Nov 24, '25May 26, '26Nov 20, '26
  • NBIX +6.6%
  • UTHR +16.2%

Head to head

MetricNBIXUTHR
Price$150.57$554.73
Change today▼ 3.84%▼ 0.78%
Market cap$15.24B$23.63B
Return, 3 months-1.6%+8.2%
Return, year to date+6.2%+13.8%
Return, 1 year+6.2%+16.8%
P/E (TTM)22.320.9
P/B3.93.8
P/E percentile vs own 5y8th96th
Dividend yield––
Revenue growth (YoY, latest qtr)+41.2%+4.1%
Net profit growth (YoY)-1.4%-23.6%
Gross margin97.7%86.3%
Operating margin24.6%39.4%
Net margin19.0%38.6%
Return on equity20.4%19.1%
Analyst target vs. price+37.7%+23.0%
Analyst buy share84%79%
RSI (14)4342
30-day volatility50.0%31.9%
Max drawdown, 1 year-27.2%-20.9%
Trend readLeaning bearishMixed
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • UTHR is the largest of the group by market value.
  • UTHR has returned the most over the past year.
  • UTHR carries the lowest trailing P/E.
  • NBIX is growing revenue fastest.
  • UTHR keeps the most profit per dollar of sales.
  • UTHR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top